Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson's disease: a systematic review and meta-analysis

J Wang, L Xue, J Jiang, F Liu, P Wu, J Lu… - NPJ Digital …, 2024 - nature.com
Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the
diagnosis of Parkinson's disease (PD). We aim to systematically review the diagnostic …

Identification of Parkinson's disease and multiple system atrophy using multimodal PET/MRI radiomics

J Sun, C Cong, X Li, W Zhou, R Xia, H Liu, Y Wang… - European …, 2024 - Springer
Objectives To construct a machine learning model for differentiating Parkinson's disease
(PD) and multiple system atrophy (MSA) by using multimodal PET/MRI radiomics and …

Clinical and neuroimaging features of the progressive supranuclear palsy-corticobasal degeneration continuum

JL Whitwell - Current opinion in neurology, 2023 - journals.lww.com
The findings help improve the imaging-based diagnosis of PSP and CBD, allow more
targeted prognostic estimates for patients accounting for phenotype or disease, and will aid …

Auto-classification of Parkinson's disease with different motor subtypes using arterial spin labelling MRI based on machine learning

J Xiong, H Zhu, X Li, S Hao, Y Zhang, Z Wang, Q Xi - Brain sciences, 2023 - mdpi.com
The purpose of this study was to automatically classify different motor subtypes of
Parkinson's disease (PD) on arterial spin labelling magnetic resonance imaging (ASL-MRI) …

The value of PET/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study

X Du, H Zhao, Y Li, Y Dai, L Gao, Y Li, K Fan… - npj Parkinson's …, 2024 - nature.com
Positron emission tomography/computed tomography (PET/CT) is a molecular imaging
method commonly used to diagnose and differentiate Parkinson's disease (PD). This study …

Towards AI-driven neuroepigenetic imaging biomarker for Alcohol Use Disorder: A Proof-of-Concept Study

TM Dagnew, CEJ Tseng, CH Yoo, MM Makary… - iScience, 2024 - cell.com
Alcohol use disorder (AUD) is a disorder of clinical and public health significance requiring
novel and improved therapeutic solutions. Both environmental and genetic factors play a …

Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4

J Tang, C Liu, C Liu, Q Hu, Y Fang, Z Chen - EJNMMI research, 2024 - Springer
Background Parkinson's disease (PD) is a prevalent neurodegenerative disorder worldwide,
diagnosed based on classic symptoms like motor dysfunction and cognitive impairments …

Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism

Y Yang, X Li, J Lu, J Ge, M Chen, R Yao… - Neural Regeneration …, 2025 - journals.lww.com
Nowadays, presynaptic dopaminergic positron emission tomography, which assesses
deficiencies in dopamine synthesis, storage, and transport, is widely utilized for early …

Current Opinion of Neurology–Neuroimaging: Clinical and neuroimaging features of the PSP-CBD continuum

JL Whitwell - Current opinion in neurology, 2023 - pmc.ncbi.nlm.nih.gov
Purpose of review: To discuss how recent work has increased our understanding of
progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). The …

Using Deep Learning to differentiate between Parkinson's Disease and Multiple System Atrophy based on PET and MRI images

H Tan, B Luo, C Cong - 2023 IEEE International Conference on …, 2023 - ieeexplore.ieee.org
Accurate early diagnosis of Parkinson's disease (PD) is challenging due to symptom overlap
with atypical parkinsonian syndromes, such as multiple system atrophy (MSA), underscoring …